Table 3. Adverse Events.
| Adverse event | No. of participants (%) | P valuea | |
|---|---|---|---|
| Placebo (n = 180) | Meloxicam (n = 184) | ||
| Organ system affected | |||
| Gastrointestinal | 6 (3) | 12 (7) | .23 |
| Renal | 0 | 1 (1) | >.99 |
| Liver | 0 | 0 | |
| Cardiovascular | 4 (2) | 1 (1) | .21 |
| Other | 15 (8) | 13 (7) | .70 |
| Serious adverse event | 3 (2) | 4 (2) | >.99 |
Obtained from Fisher exact test.